India Should Have Its Own Pharmaceutical Standards, Says Finance Minister Nirmala Sitharaman
Finance Minister Nirmala Sitharaman advocates for India to establish a “Bharat Food and Drug Administration (FDA)” to set global standards for pharmaceutical products.
Sitharaman was speaking at the 8th India Ideas Conclave in Bengaluru. The minister was suggesting the changes India should make to build its brand in the future for the globe.
“India is setting standards in pharmaceuticals. The first thing all of us have to focus our attention on is you don't need a US FDA standard. You may take it very well because that helps you with exports. But, can we in India not have a Bharat FDA," she said, adding, "Food and Drugs administration which can give global standards of benchmarks. If you reach that benchmark, your pharmaceutical products are going to be good enough, or even unsurpassed,” she said.
Sitharaman further said that people outside India are willing to recognize the brand of India, which dominated in science. She took the example of Austrian-Irish physicist Erwin Schrödinger, who had said that most of his ideas and theories were heavily influenced by Vedanta. “We need to continue with it, and Brand Bharat should speak for excellence in science and, of course, now technology,” she said.
The minister also said that India should use the advent of quick commerce to brand India as a destination of innovative solutions. “Our gig economy startups, especially quick commerce, for instance, are truly one of the kinds of innovation that only India has. Use this to brand India as a destination of innovative solutions to modern urban needs,” she said.
This will serve as an incentive or call to scale up internationally, catapulting Indian enterprises with a strong Bharatiya identity to become some of the biggest players in the international tech business space, she further said.
However, the advent of this does not mean brick-and-mortar shops are not doing well. While they are being challenged by quick commerce, they need to be supported, the minister added.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.
-
Why Amazon And Flipkart Are Struggling To Beat Meesho In India's Smaller Cities
With 274 million users and lowest-cost logistics, Meesho is defending its value commerce crown against giants like Amazon and Flipkart.